prof. dr. E.E. Voest
prof. dr. E.E. Voest
- Department of Medical Oncology
Research Programs
Biography
Biography
Emile Voest is professor of Medical Oncology, senior group leader at the Netherlands Cancer Institute, senior scientist of the Oncode Institute, and translational scientist. He is the current chair of the board of directors of Cancer Core Europe, a collaboration of 7 excellent comprehensive cancer centers. Until 2021, he served as executive medical director of the Netherlands Cancer Institute. He is also an independent, non-executive board member of Sanofi, is co-founder and serves on the non-executive board of the Hartwig Medical Foundation. He recently has co-founded Mosaic Therapeutics, devoted to developing new combinatorial treatments in a specific genomic background.
His academic group is devoted to bringing precision medicine to patients and is focused on large scale genomic sequencing of patients with metastatic cancer, the development of co-culture models of primary cultures of tumors (i.c. organoids) and immune cells to improve drug development and immunotherapy and to determine which treatment is best for a specific patient via computational, integrated approaches.
Side Activities
1999- Professor of Medical Oncology, University of Utrecht, University Medical Center, Utrecht (UP)
2010- Chair of the Scientific Advisory Board of InteRNA (PtP)
2013- Editorial board of Clinical Cancer Research (UP)
2015- Editorial board of JAMA Oncology (UP)
2015- Member of supervisory board Hartwig Medical Foundation (UP)
2016- Editorial board ESMO Open, Cancer Horizons (UP)
2016- Executive Board of Cancer Core Europe (UP)
2016- Advisor Biogeneration Ventures (PtP)
2019- Senior Group Leader of the Oncode Institute (UP)
2019- Advisor of Agalia Venture Capital (UP)
2019- Managing director, Executive Board of Directors, Cancer Core Europe (UP)
2020-2022 Advisor Frame Therapeutics (UP)
2021- Scientific Advisory Committee (SAC) for Omico (trading as the Australian Genomic Cancer Medicine Centre (AGCMC) (UP)
2021- Clinical Advisory Board Cambridge Cancer Center, UK (UP)
2021- Scientific Advisory Board Institute Gustave Roussy, Paris, France (PtP)
2021- Scientific Advisory Board GROW Oncology, Maastricht, Netherlands (UP)
2022- Independent, non-executive board member Sanofi, Paris, France (PtP)
2022- Co-founder Mosaic Therapeutics, Cambridge, UK (PtP)
2022- Board member Center for Personalized Cancer Treatment (UP)
UP=unpaid
PtP= paid to person
Research Output (297)
Schipper L. J., Samsom K. G., Snaebjornsson P., Battaglia T., Bosch L. J.W., Lalezari F., Priestley P., Shale C., van den Broek A. J., Jacobs N., Roepman P., van der Hoeven J. J.M., Steeghs N., Vollebergh M. A., Marchetti S., Cuppen E., Meijer G. A., Voest E. E., Monkhorst K. Dec 2022, In: ESMO open. 7
Schipper Luuk J., Zeverijn Laurien J., Garnett Mathew J., Voest Emile E. 1 Jul 2022, In: Cancer Discovery. 12 , p. 1634-1641 8 p.
Zhang Zhengkui, Kong Xiangjun, Ligtenberg Maarten A., van Hal-van Veen Susan E., Visser Nils L., de Bruijn Beaunelle, Stecker Kelly, van der Helm Pim W., Kuilman Thomas, Hoefsmit Esmée P., Vredevoogd David W., Apriamashvili Georgi, Baars Beau, Voest Emile E., Klarenbeek Sjoerd, Altelaar Maarten, Peeper Daniel S. 21 Jun 2022, In: Cell Reports Medicine. 3 , p. 1-25
van Berge Henegouwen J M, Jebbink M, Hoes L R, van der Wijngaart H, Zeverijn L J, van der Velden D L, Roepman P, de Leng W W J, Jansen A M L, van Werkhoven E, van der Noort V, van der Wekken A J, de Langen A J, Voest E E, Verheul H M W, Smit E F, Gelderblom H 15 Jun 2022, In: European Journal of Cancer. 171 , p. 114-123 10 p.
Mulder Jorn, van Stuijvenberg Odile C., van Hennik Paula B., Voest Emile E., Pasmooij Anna M.G., Stoyanova-Beninska Violeta, de Boer Anthonius 14 Jun 2022, In: Frontiers in medicine. 9 , p. 1-12
van Berge Henegouwen J M, van der Wijngaart H, Zeverijn L J, Hoes L R, Meertens M, Huitema A D R, Devriese L A, Labots M, Verheul H M W, Voest E E, Gelderblom H 22 May 2022, In: Cancer Chemotherapy and Pharmacology. 90 , p. 97-104 8 p.
Tamborero David, Dienstmann Rodrigo, Rachid Maan Haj, Boekel Jorrit, Lopez-Fernandez Adria, Jonsson Markus, Razzak Ali, Braña Irene, De Petris Luigi, Yachnin Jeffrey, Baird Richard, Loriot Yohann, Massard Christophe, Martin-Romano Patricia, Opdam Frans, Schlenk Richard F., Vernieri Claudio, Masucci Michele, Villalobos Xenia, Chavarria Elena, Anand Shubha, Baars Danny, Bajalica-Lagercrantz Svetlana, Baird Richard, Bierkens Mariska, Blomqvist Lennart, Bono Costanza, De Petris Luigi, Doherty Gary J., Forest Arnauld, Fornerone Valentina, Gabaldi Paola, Haglund Felix, Hartman Johan, Horak Peter, Jutzi Tanja, Kasanicki Mary, Kreutzfeldt Simon, Le Cornet Lucian, Lewensohn Rolf, Lindberg Johan, Lopez Carlos, Lundqvist Andreas, Martin Jose Ezequiel, Meijer Gerrit, Muñoz Susana, Camus Maud Ngo, Nicotra Claudio, Nuciforo Paolo, Voest Emile, May 2022, In: Nature Cancer. 3 , p. 649-649 1 p.
van Waalwijk van Doorn-Khosrovani Sahar Barjesteh, Zeverijn Laurien J., Voest Emile E. May 2022, In: The Lancet Oncology. 23 , p. e203-e203 1 p.
Mateo Joaquin, Steuten Lotte, Aftimos Philippe, André Fabrice, Davies Mark, Garralda Elena, Geissler Jan, Husereau Don, Martinez-Lopez Iciar, Normanno Nicola, Reis-Filho Jorge S., Stefani Stephen, Thomas David M., Westphalen C. Benedikt, Voest Emile Apr 2022, In: Nature Medicine. 28 , p. 658-665 8 p.
Kester Lennart, Seinstra Danielle, van Rossum Annelot G.J., Vennin Claire, Hoogstraat Marlous, van der Velden Daphne, Opdam Mark, van Werkhoven Erik, Hahn Kerstin, Nederlof Iris, Lips Ester H., Mandjes Ingrid A.M., van Leeuwen-Stok A. Elise, Canisius Sander, van Tinteren Harm, Imholz Alex L.T., Portielje Johanneke E.A., Bos Monique E.M.M., Bakker Sandra D., Rutgers Emiel J., Horlings Hugo M., Wesseling Jelle, Voest Emile E., Wessels Lodewyk F.A., Kok Marleen, Oosterkamp Hendrika M., van Oudenaarden Alexander, Linn Sabine C., van Rheenen Jacco 1 Mar 2022, In: Clinical Cancer Research. 28 , p. 960-971 12 p.